Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 vaccine uptake low among pregnant women in U.S., study finds

Despite the availability of vaccines, the U.S. CDC reports that there has been a lack of pregnant women who are getting vaccinated against SARS-CoV-2.

21 Jun 2021

Study shows that COVID-19 was present in five U.S. states in December 2019, even before the first reported case in China

In a recent study, a group of researchers aimed to identify exactly how early SARS-CoV-2 was circulating throughout the United States.

21 Jun 2021

Anti-coronavirus molecules from microbes could be key to new treatments

Microbes in the gut that produce beneficial compounds could hold the key to treating coronavirus symptoms.

21 Jun 2021

Effects of COVID-19 infection persist in patients even post-treatment

Patients infected by COVID-19 suffer cognitive and behavioral problems lasting even 2 months post-hospital release.

21 Jun 2021

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

A recent study discusses the findings of a study on patients with hematologic cancers who received convalescent plasma therapy following their diagnosis of COVID-19.

21 Jun 2021

How symptom reporting among hospital employees can be used to monitor the spread of COVID-19 within the community

A recent study discusses the potential utility of daily symptom tracking tools to estimate the number of COVID-19 hospitalizations that will occur within one week.

21 Jun 2021

New test is cheaper, easier, and can reliably diagnose SARS-CoV-2 infection

New lateral flow test Vigilant is cheaper, easier to use and as reliable as the current gold standard PCR test for diagnosing SARS-CoV-2 infection.

21 Jun 2021

Benefits of COVID-19 vaccination outweigh the complications, long-term effects of the disease

An international study, headed by Antonio Hernández, Professor of the Department of Legal Medicine, Toxicology and Physical Anthropology of the University of Granada, has reviewed the assessment reports of the European Medicines Agency regarding the Coronavirus vaccines produced by Pfizer, Moderna, and AstraZeneca.

21 Jun 2021

Pattern Computer develops novel test for 15 sec diagnosis of COVID-19

Pattern Computer,® Inc. has developed a novel test for near real-time diagnosis of SARS-CoV-2 infections.

21 Jun 2021

Study: Patients with two SARS-CoV-2 variants are less likely to be asymptomatic compared to control group

Although two SARS-CoV-2 variants are associated with higher transmission, patients with these variants show no evidence of higher viral loads in their upper respiratory tracts compared to the control group, a Johns Hopkins School of Medicine study found.

21 Jun 2021

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

Researchers from Yonsei University in South Korea have found that certain commensal bacteria that reside in the human intestine produce compounds that inhibit SARS-CoV-2.

21 Jun 2021

Common blood pressure drug not effective in reducing hospitalization for mildly-ill COVID-19 outpatients

University of Minnesota Medical School researchers determined that the common blood pressure medication, losartan, is not effective in reducing hospitalization for mildly-ill COVID-19 outpatients.

18 Jun 2021

Study explores COVID-19 outcomes in people with RA

Arani Vivekanantham and colleagues investigated the association between RA and the risk of COVID-19 diagnosis, hospitalization with COVID-19,and COVID-19-related death.

18 Jun 2021

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Due to sample size limitations, previous studies of DMARD use and COVID-19 outcomes have combined several different rheumatic diseases and medications, and investigated a single outcome- for example, the risk of hospitalization.

18 Jun 2021

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

New research from scientists at the University of Pennsylvania, USA, demonstrates that cyclosporine A (CSA), a calcineurin inhibitor that modulates cytokine production, may have potential antiviral properties against coronaviruses.

18 Jun 2021

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

A team of scientists from the United States has recently revealed the antiviral efficacy of stem-loop RNA 14, a RIG-1 agonist, in controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in mice. The compound reduces the risk of severe coronavirus disease 2019 (COVID-19) by inhibiting viral replication in the lower respiratory tract. The study is currently available on the bioRxiv* preprint server.

18 Jun 2021

Scientists develop low-cost lab-on-paper device for rapid and accurate detection of SARS-CoV-2

A team of scientists from the University of Connecticut, USA, has developed a low-cost lab-on-paper technology to rapidly and easily detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The work has recently been published in a Royal Society of Chemistry’s Lab on a Chip journal.

18 Jun 2021

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

COVID-19 vaccine uptake low among pregnant women in U.S., study finds

Study shows that COVID-19 was present in five U.S. states in December 2019, even before the first reported case in China

Anti-coronavirus molecules from microbes could be key to new treatments

Effects of COVID-19 infection persist in patients even post-treatment

Can convalescent plasma therapy improve COVID-19 outcomes in patients with hematologic cancers?

How symptom reporting among hospital employees can be used to monitor the spread of COVID-19 within the community

New test is cheaper, easier, and can reliably diagnose SARS-CoV-2 infection

Benefits of COVID-19 vaccination outweigh the complications, long-term effects of the disease

Pattern Computer develops novel test for 15 sec diagnosis of COVID-19

Study: Patients with two SARS-CoV-2 variants are less likely to be asymptomatic compared to control group

Commensal bacteria in the human intestine produce compounds that inhibit SARS-CoV-2

Common blood pressure drug not effective in reducing hospitalization for mildly-ill COVID-19 outpatients

Study explores COVID-19 outcomes in people with RA

Baseline use of DMARDs linked with COVID-19 severity in rheumatoid arthritis patients

Could a fungus-derived compound reduce hyperinflammation in severe COVID-19?

RIG-1 agonist shows potent antiviral efficacy against SARS-CoV-2 infection

Scientists develop low-cost lab-on-paper device for rapid and accurate detection of SARS-CoV-2

Combination of interferon-α and nafamostat inhibits SARS-CoV-2 in vivo

Breathonix 60-Second COVID-19 Breath Test Powered by IONICON

COVID-19 outbreak in Mauritius dominated by new SARS-CoV-2 variant B.1.1.318

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in